Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 26, 2019
Investigation on core-fucosylated prostate-specific antigen as a refined biomarker for differentiation of benign prostate hyperplasia and prostate cancer of different aggressivenessRobert Lang, Vinzent Rolny, Andreas Leinenbach, et al.
Clinical Chemistry|May 21, 2014
Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluidAndreas Leinenbach, Josef Pannee, Thomas Dülffer, et al.
Glycobiology|February 8, 2021
Glycosylation of recombinant rabbit immunoglobulins influences protease susceptibility as shown by comprehensive mass spectrometric glycan analysisIrene Friligou, Jana Gassner, Dominic Knoblauch, et al.
Electrophoresis|October 29, 2009
De novo peptide sequencing by tandem MS using complementary CID and electron transfer dissociationAndreas Bertsch, Andreas Leinenbach, Anton Pervukhin, et al.
Clinical Biochemistry|May 27, 2019
Method comparison study of the Elecsys® β-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MSLeslie M Shaw, Oskar Hansson, Ekaterina Manuilova, et al.
Frontiers in Immunology|September 27, 2019
Sensitization of Tumors for Attack by Virus-Specific CD8+ T-Cells Through Antibody-Mediated Delivery of Immunogenic T-Cell EpitopesJulian P Sefrin, Lars Hillringhaus, Olaf Mundigl, et al.
Clinical Chemistry and Laboratory Medicine|June 28, 2018
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurementsUlf Andreasson, Julia Kuhlmann, Josef Pannee, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 25, 2016
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisationJulia Kuhlmann, Ulf Andreasson, Josef Pannee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 12, 2015
Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluidTobias Bittner, Henrik Zetterberg, Charlotte E Teunissen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 6, 2020
First amyloid β1-42 certified reference material for re-calibrating commercial immunoassaysSébastien Boulo, Julia Kuhlmann, Ulf Andreasson, et al.
Pageof 2